Stericycle (NASDAQ:SRCL) Price Target Cut to $55.00 by Analysts at Robert W. Baird

Stericycle (NASDAQ:SRCL) had its price target lowered by Robert W. Baird from $62.00 to $55.00 in a report issued on Friday, Benzinga reports. The firm currently has a neutral rating on the business services provider’s stock.

Other equities analysts also recently issued research reports about the company. Stifel Nicolaus raised their target price on Stericycle from $70.00 to $75.00 and gave the company a buy rating in a research report on Thursday, February 29th. Truist Financial raised their target price on Stericycle from $50.00 to $57.00 and gave the company a hold rating in a research report on Thursday, February 29th. StockNews.com downgraded Stericycle from a buy rating to a hold rating in a research report on Tuesday, April 2nd. Wells Fargo & Company raised their target price on Stericycle from $40.00 to $48.00 and gave the company an underweight rating in a research report on Friday, March 1st. Finally, Royal Bank of Canada restated an outperform rating and issued a $69.00 target price on shares of Stericycle in a research report on Thursday, March 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of Hold and an average price target of $60.80.

Stericycle Stock Performance

Shares of SRCL stock opened at $46.31 on Friday. The business’s 50 day moving average is $51.35 and its two-hundred day moving average is $48.17. The company has a current ratio of 1.11, a quick ratio of 0.94 and a debt-to-equity ratio of 0.55. Stericycle has a 12-month low of $37.78 and a 12-month high of $57.06.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. The company had revenue of $664.90 million for the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. Stericycle’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.49 earnings per share. On average, equities analysts expect that Stericycle will post 2.32 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stericycle

A number of institutional investors have recently added to or reduced their stakes in SRCL. Citigroup Inc. increased its stake in Stericycle by 0.6% during the third quarter. Citigroup Inc. now owns 46,953 shares of the business services provider’s stock worth $2,099,000 after acquiring an additional 285 shares during the last quarter. Strategic Blueprint LLC increased its stake in Stericycle by 6.5% during the third quarter. Strategic Blueprint LLC now owns 5,283 shares of the business services provider’s stock worth $236,000 after acquiring an additional 322 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its stake in Stericycle by 4.9% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 7,243 shares of the business services provider’s stock worth $359,000 after acquiring an additional 336 shares during the last quarter. Retirement Systems of Alabama increased its stake in Stericycle by 0.3% during the fourth quarter. Retirement Systems of Alabama now owns 115,880 shares of the business services provider’s stock worth $5,743,000 after acquiring an additional 355 shares during the last quarter. Finally, Arizona State Retirement System increased its stake in Stericycle by 1.4% during the third quarter. Arizona State Retirement System now owns 26,322 shares of the business services provider’s stock worth $1,177,000 after acquiring an additional 358 shares during the last quarter. Hedge funds and other institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.